Key result
Automated intra-QRS peaks predict ~41% higher ventricular arrhythmia risk per peak in HCM patients.
Why the study?
Patients with HCM are at risk of ventricular arrhythmia from abnormal electrical activation, but whether quantifying intra-QRS peaks in high-resolution ECGs can predict late ventricular arrhythmias remained unknown.
Does automated quantification of intra-QRS peaks (QRSp) from high-resolution ECGs predict late ventricular arrhythmias in patients with hypertrophic cardiomyopathy?
Cohort (n=143)
Yes
Does automated quantification of intra-QRS peaks (QRSp) from high-resolution ECGs predict late ventricular arrhythmias in patients with hypertrophic cardiomyopathy?
Effect estimate: HR 1.41 per QRS peak
Absolute Event Rate: 4.4% vs 0.98%
p-value: p=0.009
Automated quantification of intra-QRS peaks from high-resolution ECGs independently predicts late ventricular arrhythmias in patients with hypertrophic cardiomyopathy, potentially improving patient selection for prophylactic ICDs.
QRSp may support VA risk stratification in HCM; hypothesis-generating for ICD selection pending prospective validation.
Background Patients with hypertrophic cardiomyopathy (HCM) are at risk of ventricular arrhythmia (VA) attributed to abnormal electrical activation arising from myocardial fibrosis and myocyte disarray. We sought to quantify intra‐QRS peaks (QRSp) in high‐resolution ECGs as a measure of abnormal activation to predict late VA in patients with HCM. Methods and Results Prospectively enrolled patients with HCM (n=143, age 53±14 years) with prophylactic implantable cardioverter‐defibrillators had 3‐minute, high‐resolution (1024 Hz), digital 12‐lead ECGs recorded during intrinsic rhythm. For each precordial lead, QRSp was defined as the total number of peaks detected in the QRS complex that deviated from a smoothing filtered version of the QRS. The VA end point was appropriate implantable cardioverter‐defibrillator therapy during 5‐year prospective follow‐up. After 5 years, 21 (16%) patients had VA. Patients who were VA positive had greater QRSp (6.0 [4.0–7.0] versus 4.0 [2.0–5.0]; P <0.01) and lower left ventricular ejection fraction (57±11 versus 62±9; P =0.038) compared with patients who were VA negative, but had similar established HCM risk metrics. Receiver operating characteristic analysis revealed that QRSp discriminated VA (area under the curve=0.76; P <0.001), with a QRSp ≥4 achieving 91% sensitivity and 39% specificity. The annual VA rate was greater in patients with QRSp ≥4 versus QRSp <4 (4.4% versus 0.98%; P =0.012). In multivariable Cox regression, age <50 years (hazard ratio [HR], 2.53; P =0.009) and QRSp (HR per QRS peak, 1.41; P =0.009) predicted VA after adjusting for established HCM risk metrics. In patients aged <50 years, the annual VA rate was 0.0% for QRSp <4 compared with 6.9% for QRSp ≥4 ( P =0.012). Conclusions QRSp predicted VA in patients with HCM who were eligible for an implantable cardioverter‐defibrillator after adjusting for established HCM risk metrics, such that each additional QRS peak increases VA risk by 40%. QRSp <4 was associated with a <1% annual VA risk in all patients, and no VA risk among those aged <50 years. This novel ECG metric may improve patient selection for prophylactic implantable cardioverter‐defibrillator therapy by identifying those with low VA risk. These findings require further validation in a lower risk HCM cohort. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02560844.
No takes yet. Share an insight, caveat, or question.
Suszko et al. (2022) conducted a cohort in Hypertrophic cardiomyopathy (n=143). Intra-QRS peaks (QRSp) ≥4 vs. QRSp <4 was evaluated on Appropriate implantable cardioverter-defibrillator therapy (ventricular arrhythmia) (HR 1.41 per QRS peak, p=0.009). Automated quantification of intra-QRS peaks (QRSp) predicted ventricular arrhythmia in HCM patients, with each additional peak increasing risk by 40% (HR 1.41; P=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: